|
Market Closed -
Nasdaq
21:00:00 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 35.78 USD | -5.14% |
|
-13.09% | -15.37% |
| 10-12 | UBS Initiates Coverage on Nektar Therapeutics With Neutral Rating, $53 Price Target | MT |
| 10-12 | Leerink Partners Initiates Nektar Therapeutics at Outperform, $130 Price Target | MT |
| Market Cap | 1.22B 1.09B 1.01B 916M 1.73B 116B 1.76B 12.1B 4.74B 60.5B 4.58B 4.49B 193B | P/E 2026 * |
-4.43x | P/E 2027 * | -3.41x |
|---|---|---|---|---|---|
| Enterprise Value | 613M 545M 505M 460M 868M 58.21B 881M 6.07B 2.38B 30.37B 2.3B 2.25B 96.83B | EV / Sales 2026 * |
14.7x | EV / Sales 2027 * | 15.1x |
| Free-Float |
99.62% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NKTR | Delayed | |
CBOE
| NKTR | Real-time | |
|
Tradegate
| ITH0 | Real-time | |
|
Deutsche Boerse AG
| ITH0 | Delayed | |
|
Boerse Muenchen
| ITH0 | Real-time | |
|
Börse Stuttgart
| ITH0 | Delayed | |
|
Xetra
| ITH0 | Delayed |
Last Transcript: Nektar Therapeutics
| 1 day | -5.14% | ||
| 1 week | -13.09% | ||
| Current month | -40.90% | ||
| 1 month | -46.90% | ||
| 3 months | -46.64% | ||
| 6 months | -57.40% | ||
| Current year | -15.37% |
| 1 week | 35.61 |  | 40.98 |
| 1 month | 35.61 | | 69.84 |
| Current year | 33.4 | | 109 |
| 1 year | 33.4 | | 109 |
| 3 years | 6.19 | | 109 |
| 5 years | 6.19 | | 266.85 |
| 10 years | 6.19 | | 1,670.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 73 | 31/12/2006 |
Linda Rubinstein
DFI | Director of Finance/CFO | 60 | 14/05/2026 |
| Chief Tech/Sci/R&D Officer | 52 | 30/06/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Roy Whitfield
BRD | Director/Board Member | 72 | 31/07/2000 |
Robert Chess
CHM | Chairman | 69 | 30/04/1992 |
Howard Robin
BRD | Director/Board Member | 73 | 31/01/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/09/26 | Free | Director | 6,000 | 0.0176% | ||
| 23/09/26 | Free | Director | 6,000 | 0.0176% | ||
| 23/09/26 | Free | Director | 6,000 | 0.0176% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.14% | -13.09% | -34.90% | +352.63% | 1.22B | |
| -6.60% | -8.56% | +42.79% | +64.16% | 65B | |
| -4.09% | -0.11% | +2.31% | +54.81% | 51.19B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 51.2B | |
| -1.53% | +2.70% | +29.72% | +34.13% | 43.93B | |
| -1.34% | +4.12% | +16.05% | +112.18% | 41.96B | |
| -5.97% | -6.22% | +258.21% | +421.57% | 38.14B | |
| +6.53% | +8.02% | +15.74% | +53.94% | 33.24B | |
| -0.90% | -10.49% | +31.48% | -1.63% | 25.2B | |
| -2.76% | -9.54% | -16.53% | -9.55% | 22.03B | |
| Average | -2.18% | -2.81% | +35.50% | +112.40% | 37.31B | |
| Weighted average by Cap. | -2.31% | -1.24% | +43.30% | +89.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41.82M 37.18M 34.46M 31.35M 59.16M 3.97B 60.11M 414M 162M 2.07B 157M 154M 6.6B | 53.42M 47.48M 44.01M 40.04M 75.56M 5.07B 76.77M 529M 207M 2.65B 200M 196M 8.43B |
| Net income | -246M -219M -203M -185M -349M -23.39B -354M -2.44B -957M -12.2B -925M -905M -38.9B | -363M -322M -299M -272M -513M -34.42B -521M -3.59B -1.41B -17.96B -1.36B -1.33B -57.25B |
| Net Debt | -608M -541M -501M -456M -861M -57.74B -874M -6.02B -2.36B -30.13B -2.28B -2.23B -96.05B | -415M -369M -342M -311M -587M -39.41B -597M -4.11B -1.61B -20.57B -1.56B -1.53B -65.56B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | US$35.78 | -5.14% | 784,295 |
| 15/10/26 | US$37.72 | +2.25% | 684,249 |
| 14/10/26 | US$36.89 | -2.72% | 1,002,708 |
| 13/10/26 | US$37.92 | -4.82% | 2,044,401 |
| 12/10/26 | US$39.84 | -3.23% | 1,048,221 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NKTR Stock
Select your edition
All financial news and data tailored to specific country editions
